Roger Zickfeld

Roger Zickfeld focuses on the medical device, diagnostics and pharmaceutical industries for Columbia Capital Securities. Clients turn to him for advisory services with an emphasis on raising capital, business strategy, and mergers and acquisitions. His career includes more than 25 years of experience as an investment banker, medical device/life sciences corporate executive, and management consultant.

Mr. Zickfeld was a managing director at investment banks Salem Partners and B. Riley & Co. where he focused on medical device and pharmaceutical corporate finance and M&A. Previously he was a top executive for 13 years with Karl Storz Endoscopy, the $2 billion global medical devices firm, where he had broad managerial and P&L responsibility. Mr. Zickfeld was President of the company's renal lithotripsy division and CFO of the overall US operations. He was also President of the company's captive finance subsidiary, and a senior executive of the company's major distribution entities and fiber optics manufacturing facility. In addition to having extensive medical device operating experience, Mr. Zickfeld was the CEO of a life sciences start-up, Gene Connections. In addition, Mr. Zickfeld was a management consultant for five years in KPMG’s corporate strategy and corporate finance practices, and before attending graduate school he spent several years with Ernst & Young.

Recent advisory and investment banking projects have been in the fields of surgical imaging, pharmaceuticals, surgical instrumentation, interventional cardiology, digital health, diagnostic brain scanning, biologics, and image processing for both diagnostics and surgical applications.

Mr. Zickfeld earned an MBA degree from UCLA and graduated Magna Cum Laude from the University of Southern California with a Bachelor of Science degree in Business Administration. He is a Certified Public Accountant (inactive) and is a former board member of Ikona Medical, Inc. and the Los Angeles Chamber Orchestra.